Acetaminophen relieves pain and lowers fever primarily by acting on the brain and spinal cord, not by reducing inflammation at the site of an injury. This makes it fundamentally different from ibuprofen and other NSAIDs, which work throughout the body. Despite being one of the most widely used drugs in the world, its exact mechanism has remained surprisingly difficult to pin down, and researchers now believe it works through several overlapping pathways at once.
Pain Relief Starts in the Brain
The traditional explanation for how acetaminophen works centers on enzymes called COX-1 and COX-2. These enzymes produce prostaglandins, chemical messengers that amplify pain signals and raise body temperature. NSAIDs like ibuprofen block both COX enzymes aggressively in tissues throughout the body, which is why they reduce swelling at the source of an injury. Acetaminophen takes a different approach: it reduces COX activity primarily in the central nervous system (the brain and spinal cord) rather than in peripheral tissues like muscles, joints, or skin.
Interestingly, acetaminophen doesn’t attach to the same spot on COX enzymes that NSAIDs do. Instead, it reduces enzyme activity through an alternative chemical mechanism. Lab studies show it actually has about 4.4 times more selectivity for COX-2 than COX-1, and at therapeutic doses it can inhibit COX-2 by more than 80%, a level comparable to prescription anti-inflammatory drugs. Yet it still doesn’t meaningfully reduce inflammation in the body. The reason is that its effects concentrate in the brain, where prostaglandin reduction translates into less pain perception and lower fever rather than reduced swelling at an injury site.
The Endocannabinoid Connection
One of the more surprising discoveries about acetaminophen is that it interacts with your body’s own cannabinoid system, the same network that cannabis compounds act on. After you take acetaminophen, your liver breaks it down into several byproducts. One of these, called p-aminophenol, crosses into the brain where an enzyme converts it into a compound called AM404.
AM404 turns out to be a key player. It activates cannabinoid receptors (CB1 receptors) in a brain region called the periaqueductal grey, which is a major control center for pain modulation. In animal studies, mice that lacked CB1 receptors or were given drugs to block them showed no pain relief from acetaminophen at all. When researchers blocked the enzyme that creates AM404, acetaminophen’s painkilling effect also disappeared. This strongly suggests that AM404, not acetaminophen itself, is responsible for a significant portion of the drug’s pain-relieving action.
AM404 also appears to work by boosting levels of naturally occurring cannabinoids (anandamide and 2-AG) by preventing their breakdown. So rather than introducing a foreign painkilling substance, acetaminophen essentially amplifies a pain-relief system your body already has.
How It Works in the Spinal Cord
Acetaminophen also acts at the spinal cord level, where pain signals from your body get relayed up to the brain. Here, the story involves yet another pathway. When acetaminophen is metabolized in the spinal cord by local enzymes, it produces reactive byproducts (including the same NAPQI molecule responsible for liver toxicity at high doses). In small, controlled amounts within the spinal cord, these metabolites activate a sensor called TRPA1 on the terminals of pain-sensing nerve fibers.
This activation is counterintuitive: TRPA1 is normally associated with detecting irritants. But when it’s triggered on the central terminals of these nerves inside the spinal cord, it actually reduces the activity of voltage-gated calcium and sodium channels, effectively dampening pain signal transmission. Mice genetically engineered to lack TRPA1 get no spinal pain relief from acetaminophen. Researchers have confirmed that acetaminophen metabolites are present in the spinal cord after a normal oral dose, supporting this as a real, active pathway in the body.
Additionally, acetaminophen appears to stimulate descending serotonin pathways, which are nerve circuits that run from the brainstem down into the spinal cord and act as a built-in volume knob for incoming pain signals.
How It Reduces Fever
Fever starts when your immune system releases inflammatory signaling molecules in response to an infection. These molecules reach blood vessels lining a region of the hypothalamus, the brain’s thermostat. The vessel walls respond by producing COX-2, which generates a prostaglandin called PGE2. PGE2 resets your body’s target temperature higher, and you develop a fever.
Acetaminophen lowers fever by reducing PGE2 production in the hypothalamus. But the specific enzyme it inhibits there may not be standard COX-1 or COX-2. Recent research suggests its target is a variant form of the COX-1 enzyme. Selective blockers of COX-1 and COX-2 tested individually don’t replicate acetaminophen’s temperature-lowering effect, and acetaminophen can actually push body temperature below normal (hypothermia) in non-feverish animals, something that standard COX inhibitors don’t do. This points to a distinct enzymatic target that researchers are still working to fully characterize.
Why It Doesn’t Fight Inflammation
The practical distinction that matters most is this: acetaminophen works in the brain and spinal cord, while NSAIDs work both centrally and at the site of tissue damage. Inflammation involves prostaglandins, immune cell activity, and blood vessel changes happening locally, in a swollen ankle or an arthritic knee. Because acetaminophen doesn’t meaningfully suppress COX activity in those peripheral tissues, it won’t reduce the redness, swelling, or warmth that come with inflammation. It will reduce the pain you feel from that inflammation, because it’s turning down the volume in your central nervous system, but it won’t address the underlying inflammatory process.
This is why acetaminophen works well for headaches, general aches, and fever but is less effective than ibuprofen or naproxen for conditions driven by active inflammation, like a sprained ligament or rheumatoid arthritis flare. It also explains why acetaminophen doesn’t carry the stomach and cardiovascular risks associated with NSAIDs: those side effects come from blocking prostaglandins in the gut lining and blood vessels, which acetaminophen largely spares.
What Happens After You Take It
Oral acetaminophen begins working in under an hour, and its pain-relieving and fever-reducing effects last about four to six hours per dose. The current FDA maximum for adults is 4,000 milligrams per day across all products combined, which is important because acetaminophen is an ingredient in hundreds of combination medications, from cold remedies to prescription painkillers.
Your liver handles the bulk of acetaminophen metabolism. Most of the drug is processed through safe pathways and excreted. But about 5 to 9 percent gets converted by liver enzymes into a reactive molecule called NAPQI. Under normal circumstances, your liver neutralizes NAPQI almost immediately using a protective molecule called glutathione. The problem arises when you take too much acetaminophen: glutathione stores get depleted, and NAPQI accumulates and begins damaging liver cells directly. This is the mechanism behind acetaminophen overdose, which is the leading cause of acute liver failure in the United States. The antidote, N-acetylcysteine, works by replenishing glutathione so the liver can resume neutralizing NAPQI.
The same NAPQI that causes liver damage at toxic doses appears to play a beneficial role in tiny amounts within the spinal cord, where it activates the TRPA1 pain-modulation pathway. It’s a striking example of dose and location determining whether a molecule helps or harms.